# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001731122-21-000974
Filing Date
2021-05-28
Accepted
2021-05-28 16:00:49
Documents
16
Period of Report
2021-05-25
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | e2796_8-k.htm iXBRL | 8-K | 41768
2 | EX-3.1 | e2796_ex3-1.htm | EX-3.1 | 2624
3 | GRAPHIC | img_001.jpg | GRAPHIC | 408990
4 | GRAPHIC | img_002.jpg | GRAPHIC | 314572
5 | GRAPHIC | img_003.jpg | GRAPHIC | 96007
| Complete submission text file | 0001731122-21-000974.txt |  | 1351623

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL SCHEMA FILE | avxl-20210525.xsd | EX-101.SCH | 3017
7 | XBRL LABEL FILE | avxl-20210525_lab.xml | EX-101.LAB | 34238
8 | XBRL PRESENTATION FILE | avxl-20210525_pre.xml | EX-101.PRE | 22353
9 | EXTRACTED XBRL INSTANCE DOCUMENT | e2796_8-k_htm.xml | XML | 3814

Mailing Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163
Business Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163 800-689-3939
ANAVEX LIFE SCIENCES CORP. (Filer) CIK: 0001314052 (see all company filings)

EIN.: 208365999 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-37606 | Film No.: 21979983
SIC: 8731 Services-Commercial Physical & Biological Research